Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 100701-100750 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04301843
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
PHASE2Recruiting
131 participants
Started: Sep 25, 2020 · Completed: Oct 1, 2033
1 condition5 sponsors29 locations
NCT06266624
Tourniquet-Test in HHT
NAActive, not recruiting
92 participants
Started: Sep 25, 2020 · Completed: Jul 30, 2025
1 condition1 sponsor1 location
NCT04530227
Camrelizumab With Chemotherapy in Adults With Medically Inoperable Early Stage NSCLC
PHASE2Recruiting
30 participants
Started: Sep 25, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04544761
Resilience in Persons Following Spinal Cord Injury
N/AActive, not recruiting
28 participants
Started: Sep 25, 2020 · Completed: Dec 1, 2023
1 condition2 sponsors1 location
NCT04422652
Combination of Novel Therapies for CKD Comorbid Depression
PHASE2Recruiting
201 participants
Started: Sep 24, 2020 · Completed: Apr 1, 2026
2 conditions2 sponsors4 locations
NCT03975179
Omitting vs. Doing Intraoperative Frozen Section Biopsy for Margin Status in Breast Conserving Surgery
NARecruiting
1,292 participants
Started: Sep 24, 2020 · Completed: Jun 30, 2026
1 condition2 sponsors2 locations
NCT03909737
Oral Azithromycin to Prevent Stillbirths and Infant Mortality in Mali
PHASE4Active, not recruiting
99,700 participants
Started: Sep 24, 2020 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04052555
Testing the Addition of an Anti-cancer Drug, Berzosertib, to the Usual Treatment (Radiation Therapy) for Chemotherapy-Resistant Triple-Negative and Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast Cancer
PHASE1Active, not recruiting
42 participants
Started: Sep 24, 2020 · Completed: Apr 24, 2026
5 conditions1 sponsor14 locations
NCT04574609
Evaluation of the Impact of the Use of Hypnotherapy Performed by a Virtual Reality Toolalong the Care Pathway of Patients Undergoing Breast Cancer Treatment.
NAActive, not recruiting
27 participants
Started: Sep 24, 2020 · Completed: Jan 30, 2024
1 condition1 sponsor1 location
NCT04168502
Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML
PHASE3Recruiting
414 participants
Started: Sep 24, 2020 · Completed: Apr 30, 2027
1 condition1 sponsor48 locations
NCT04480567
AAV Gene Therapy Study for Subjects with PKU
PHASE1/PHASE2Active, not recruiting
100 participants
Started: Sep 24, 2020 · Completed: Dec 31, 2027
1 condition1 sponsor3 locations
NCT06431126
Nature and Animal-assisted Activities
NAActive, not recruiting
13 participants
Started: Sep 24, 2020 · Completed: Dec 1, 2025
2 conditions1 sponsor1 location
NCT04807881
Phase Ib Clinical Study of Keynatinib
PHASE1Recruiting
75 participants
Started: Sep 24, 2020 · Completed: Apr 10, 2028
1 condition1 sponsor4 locations
NCT04422132
Randomized Phase II Trial of Salvage Radiotherapy for Prostate Cancer In 4 Weeks v. 2 Weeks
PHASE2Active, not recruiting
134 participants
Started: Sep 24, 2020 · Completed: Dec 31, 2028
1 condition2 sponsors1 location
NCT04562129
IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients
PHASE2Recruiting
29 participants
Started: Sep 24, 2020 · Completed: Nov 30, 2029
3 conditions2 sponsors1 location
NCT04260802
A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
PHASE1/PHASE2Recruiting
116 participants
Started: Sep 24, 2020 · Completed: Sep 30, 2026
19 conditions1 sponsor5 locations
NCT04604301
Celtra Quatro Crown Study
NAActive, not recruiting
48 participants
Started: Sep 24, 2020 · Completed: Nov 1, 2027
3 conditions2 sponsors1 location
NCT04526665
Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)
PHASE3Active, not recruiting
161 participants
Started: Sep 24, 2020 · Completed: Dec 1, 2028
1 condition1 sponsor115 locations
NCT04627376
Multimodal Program for Cancer Related Cachexia Prevention
NARecruiting
60 participants
Started: Sep 24, 2020 · Completed: Jun 30, 2026
5 conditions2 sponsors1 location
NCT04543799
Evaluation of Sleep Quality in Prostate Cancer Patients Undergoing Treatment With Hormonal Therapeutic Approaches and in Patients With Full-resected Early Breast Cancer
N/ARecruiting
60 participants
Started: Sep 24, 2020 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05736523
Improving Early Detection of Melanoma Recurrence With Circulating Tumor DNA (ctDNA)
N/AActive, not recruiting
28 participants
Started: Sep 23, 2020 · Completed: Jun 30, 2025
1 condition3 sponsors2 locations
NCT03846297
Optimisation of Decision Making for Defibrillator Implantation in Hypertrophic Cardiomyopathy
N/ARecruiting
2,000 participants
Started: Sep 23, 2020 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT04573504
Antibiotics for Severe Perineal Laceration to Prevent Infection Following Repair
PHASE4Recruiting
274 participants
Started: Sep 23, 2020 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT04584008
Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics
NAActive, not recruiting
600 participants
Started: Sep 23, 2020 · Completed: Mar 31, 2025
9 conditions3 sponsors1 location
NCT04570020
Scleral Lens Fitting Using Wide-Field OCT
N/ARecruiting
258 participants
Started: Sep 23, 2020 · Completed: Dec 31, 2028
2 conditions2 sponsors1 location
NCT04521764
A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer
PHASE1Recruiting
54 participants
Started: Sep 23, 2020 · Completed: Aug 15, 2027
5 conditions1 sponsor1 location
NCT04578106
Omission of Surgery in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti-HER2-based Neoadjuvant Therapy
PHASE2Recruiting
17 participants
Started: Sep 23, 2020 · Completed: Dec 31, 2026
2 conditions3 sponsors1 location
NCT04560127
Camrelizumab in Combination With Apatinib in Patients With Radioactive Iodine-refractory Differentiated Thyroid Cancer
PHASE2Active, not recruiting
20 participants
Started: Sep 23, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04339764
Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration
PHASE1/PHASE2Recruiting
20 participants
Started: Sep 23, 2020 · Completed: May 31, 2029
2 conditions1 sponsor2 locations
NCT05615259
Comparison Between Exactech Guided Personalized Surgery (GPS) and Conventional Instrumentation of Shoulder Arthroplasty
N/ARecruiting
260 participants
Started: Sep 23, 2020 · Completed: Sep 30, 2031
2 conditions1 sponsor1 location
NCT05249153
Dexmedetomidine and Sufentanil Effect in PCA on Pediatric Patients Undergoing Scoliosis Surgery
NAActive, not recruiting
84 participants
Started: Sep 23, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04365205
Effect of Benralizumab on Airway Remodeling in Asthma
N/ARecruiting
60 participants
Started: Sep 23, 2020 · Completed: Oct 5, 2024
1 condition1 sponsor1 location
NCT04569773
Choosing Ovarian Preservation or Removal Before Surgery for Endometrial Cancer
N/AActive, not recruiting
43 participants
Started: Sep 23, 2020 · Completed: Sep 23, 2026
1 condition1 sponsor8 locations
NCT04497844
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
PHASE3Active, not recruiting
696 participants
Started: Sep 23, 2020 · Completed: Nov 1, 2027
1 condition1 sponsor387 locations
NCT04390035
BFRT in Adolescents After ACL Reconstruction
NARecruiting
120 participants
Started: Sep 23, 2020 · Completed: Apr 30, 2023
1 condition1 sponsor1 location
NCT04501276
A Phase 1b/2 Study of ADG116, ADG116 Combined With Anti-PD-1 Antibody or Anti-CD137 Antibody in Solid Tumors Patients
PHASE1Active, not recruiting
72 participants
Started: Sep 23, 2020 · Completed: Feb 1, 2025
1 condition1 sponsor4 locations
NCT03978624
Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer
PHASE2Active, not recruiting
20 participants
Started: Sep 23, 2020 · Completed: Nov 22, 2026
1 condition3 sponsors2 locations
NCT04448886
Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC
PHASE2Active, not recruiting
110 participants
Started: Sep 23, 2020 · Completed: Jun 1, 2027
4 conditions3 sponsors8 locations
NCT04557449
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
PHASE2Active, not recruiting
362 participants
Started: Sep 23, 2020 · Completed: Nov 23, 2027
4 conditions1 sponsor38 locations
NCT04584632
The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients with Symptomatic Peripheral Vascular Disease from Stenosis or Occlusion of the Femoropopliteal Artery
NARecruiting
100 participants
Started: Sep 22, 2020 · Completed: Mar 31, 2028
4 conditions1 sponsor4 locations
NCT04060017
Early Treatment of Language Impairment in Young Children With Autism Spectrum Disorder With Leucovorin Calcium
PHASE2Recruiting
80 participants
Started: Sep 22, 2020 · Completed: Jun 30, 2026
2 conditions3 sponsors2 locations
NCT03666559
Treatment With Azacitidine of Recurrent Gliomas With IDH1/2 Mutation
PHASE2Active, not recruiting
8 participants
Started: Sep 22, 2020 · Completed: Mar 23, 2024
1 condition1 sponsor1 location
NCT04356755
Subcutaneous Injections of ASC to Heal Digital Ulcers in Patients With Scleroderma.
PHASE2Recruiting
32 participants
Started: Sep 22, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor7 locations
NCT04503148
Anesthesia and Cancer Study: Renal Cell Carcinoma
NAActive, not recruiting
562 participants
Started: Sep 22, 2020 · Completed: Dec 22, 2025
1 condition1 sponsor1 location
NCT04578301
Predicting Acute-on-Chronic Liver Failure After Surgical Intervention in Chronic Liver Disease
N/ARecruiting
200 participants
Started: Sep 22, 2020 · Completed: Dec 31, 2026
5 conditions1 sponsor1 location
NCT04561557
Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System
EARLY_PHASE1Recruiting
36 participants
Started: Sep 22, 2020 · Completed: May 31, 2027
10 conditions2 sponsors1 location
NCT04390672
Multivessel TALENT
NAActive, not recruiting
1,550 participants
Started: Sep 22, 2020 · Completed: Sep 30, 2026
7 conditions1 sponsor1 location
NCT04339777
Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity
PHASE2Recruiting
66 participants
Started: Sep 22, 2020 · Completed: Nov 30, 2027
5 conditions1 sponsor1 location
NCT04842916
InteGRAtive Analysis of TuMor, Microenvironment, ImmunitY and Patient Expectation for Personalized Response Prediction in Gastric Cancer
N/ARecruiting
250 participants
Started: Sep 22, 2020 · Completed: May 22, 2027
1 condition2 sponsors5 locations
NCT05871489
Strengthening Evidence on Optimal Multidrug-resistant Tuberculosis Treatment Regimens
N/AActive, not recruiting
800 participants
Started: Sep 22, 2020 · Completed: Dec 31, 2025
2 conditions4 sponsors3 locations